Alkermes plc (ALKS)
NASDAQ: ALKS · Real-Time Price · USD
28.45
+0.64 (2.30%)
Dec 19, 2025, 4:00 PM EST - Market closed
Alkermes Employees
Alkermes had 1,800 employees as of December 31, 2024. The number of employees decreased by 300 or -14.29% compared to the previous year.
Employees
1,800
Change (1Y)
-300
Growth (1Y)
-14.29%
Revenue / Employee
$845,188
Profits / Employee
$188,237
Market Cap
4.70B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1,800 | -300 | -14.29% |
| Dec 31, 2023 | 2,100 | -180 | -7.89% |
| Dec 31, 2022 | 2,280 | 69 | 3.12% |
| Dec 31, 2021 | 2,211 | -34 | -1.51% |
| Dec 31, 2020 | 2,245 | 10 | 0.45% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ALKS News
- 8 days ago - Avadel Pharmaceuticals Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Avadel Pharmaceuticals plc - AVDL - PRNewsWire
- 15 days ago - Alkermes plc (ALKS) Presents at Evercore 8th Annual Healthcare Conference Transcript - Seeking Alpha
- 25 days ago - Alkermes to Participate in Two Upcoming Investor Conferences - Business Wire
- 4 weeks ago - Alkermes raises offer for Avadel after Lundbeck bid - Reuters
- 4 weeks ago - Alkermes plc Announces Increased Offer to Acquire Avadel Pharmaceuticals plc - PRNewsWire
- 4 weeks ago - Alkermes plc (ALKS) Shareholder/Analyst Call Transcript - Seeking Alpha
- 5 weeks ago - Lundbeck's Higher Buyout Proposal Challenges Alkermes' Pending $2 Billion Avadel Deal - Benzinga
- 5 weeks ago - H. Lundbeck Launches Bid for Avadel in Move to Scuttle Alkermes Deal - WSJ